Exploratory Study of PENNSAID Gel to Treat Symptoms of Knee Osteoarthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

August 2, 2010

Primary Completion Date

February 16, 2011

Study Completion Date

February 16, 2011

Conditions
Osteoarthritis of the Knee
Interventions
DRUG

PENNSAID Gel

2 mL applied to the front, back and sides of the knee twice a day (morning and night) for 4 weeks

DRUG

Vehicle

2 mL applied to the front, back and sides of the knee twice a day (morning and night) for 4 weeks

Trial Locations (26)

22911

Charlottesville Medical Research, Charlottesville

24018

HypotheTest, LLC, Roanoke

27262

Peters Medical Research, LLC, High Point

28144

Crescent Medical Research, Salisbury

28401

New Hanover Medical Research, Wilmington

28803

Clinical Study Center of Asheville, Asheville

29261

Radiant Research Inc., Anderson

29464

Palmetto Medical Research, Mt. Pleasant

30060

Drug Studies America, Marietta

31406

South Coast Medical Group, Savannah

32724

Avail Clinical Research, DeLand

33716

Comprehensive NeuroScience Inc., St. Petersburg

33761

Tampa Bay Medical Research, Inc, Clearwater

37660

Holston Medical Group Clinical Research, Kingsport

41018

Sterling Research, Erlanger

43212

Radiant Research Inc., Columbus

43551

Clinical Research Source, Inc., Perrysburg

45246

Sterling Research, Cincinnati

63141

Radiant Research Inc., St Louis

Sundance Clinical Research, St Louis

66206

Clinical Trials Technology, Inc., Prairie Village

76135

Benchmark Research, Fort Worth

76904

Benchmark Research, San Angelo

78215

Sun Research Institute, San Antonio

85741

Genova Clinical Research, Tucson

95816

Benchmark Research, Sacramento

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mallinckrodt

INDUSTRY